Author Archive

Dead Last: Americans Pay the Most For Worst Health Outcomes, Study Finds & Panel Discusses Causes and Solutions

Wisconsin Senator Ron Johnson recently had a panel of experts discuss the causes and solutions of America’s chronic health crisis.  While lengthy, eye-opening information is given including the fact the worst purveyor of mis and disinformation has been our own government.

  • Senator Ron Johnson, Robert F. Kennedy Jr., Mikhaila Peterson-Fuller (Jordan Peterson’s daughter), Jordan Peterson, Dr. Marty Makary, Casey Means, Calley Means, Dr. Chris Palmer, Brigham Bueller, Max Lugavere, Senator Mike Crapo, Grace Price, Vani Hari, Jason Karp, Jillian Michaels, Courtney Swan, and Alex Clark participated in this important groundbreaking meeting.

I also highly recommend this article by Cindy Perlin, LCSW, on how health insurance companies have ruined American healthcare.  In the 1900’s, health insurance had nonprofit beginnings with a mission to provide affordable healthcare, and all applicants were accepted and were charged the same premiums across the board.  ‘We’ve come a long way, baby.’

https://childrenshealthdefense.org/defender/american-healthcare-pay-most-worst-outcomes-avoidable-deaths

Dead Last: Americans Pay the Most for Worst Health Outcomes, Study Finds

The U.S. healthcare system ranks last among 10 advanced economies, according to a report released today by the Commonwealth Fund. Americans live the shortest lives and have the most avoidable deaths despite paying more for healthcare than the other nine countries.

This article was originally published by The Defender — Children’s Health Defense’s News & Views Website.

american flag, money and stethoscope

The U.S. healthcare system ranks last among 10 advanced economies, according to a report released today by the Commonwealth Fund.

Mirror, Mirror 2024: A Portrait of the Failing U.S. Health System,” the eighth such study the Commonwealth Fund has published since 2004, studied five areas of healthcare system performance: access to healthcare, the care process, administrative efficiency, equity and health outcomes.

According to the report, “The U.S. continues to be in a class by itself in the underperformance of its health care sector.”

The other countries studied include Australia, Canada, France, Germany, the Netherlands, New Zealand, Sweden, Switzerland and the United Kingdom.

The report stated:

“The nine nations we examined are more alike than different with respect to their higher and lower performance in various domains. But there is one glaring exception — the U.S. …

“The ability to keep people healthy is a critical indicator of a nation’ capacity to achieve equitable growth. In fulfilling this fundamental obligation, the U.S. continues to fail.”

The report also singled out the poor performance by the U.S. in COVID-19-related metrics, including  excess deaths resulting from the pandemic, where the U.S. ranked last.

“The U.S. has the highest rates of … excess deaths related to the pandemic for people under age 75,” the report stated.

The report also highlighted examples of countries that have achieved success with child healthcare, including the Netherlands and Switzerland.

“In the Netherlands, visits to primary care, maternity care, and child health care providers are fully covered; other health care services are covered once patients pay their annual deductible,” the report said.

“Switzerland’s small size, along with the nation’s extensive transit options and, as of 2015, increased funding for women’s health, led to improved performance, including fewer childbirth injuries and a higher rate of postpartum checkups,” the report added.

According to a research letter published in JAMA Pediatrics in July, children and teens in the U.S. are dying at higher rates than their peers in 16 other high-income countries. The U.S. infant mortality rate consistently exceeds those of other high-income countries.

In a Substack post responding to the “Mirror, Mirror 2024” report, physician and scientist Dr. Robert Malone wrote, “Clearly, the US Healthcare system is failing to provide value for money, and is failing the citizens of the United States.”

“Generally speaking, US Citizens are glad to pay more for longer, healthier lives. But in fact, we are paying the most of the ranked countries for the worst overall outcomes,” Malone wrote.

U.S. spends ‘vast amounts’ for ‘generally poor results’

One of the report’s key findings is that the U.S. lags behind its international peers considerably in terms of health system performance — yet the U.S. is also “an outlier on health care spending.”

In 1980, U.S. health expenditures were “comparable to outlays in Sweden and Germany (8.2% of GDP).” However, since then, “the U.S. has far outpaced other nations, spending more than 16 percent of its GDP on health care in 2022” — a figure “predicted to exceed 20 percent by 2035.”

According to the report, this finding reflects the “enduring U.S. dilemma of spending vast amounts for generally poor results — the very definition of a low-value health system.”

Americans ‘face the most barriers to accessing and affording health care’

Americans also face the most barriers to accessing and affording healthcare, the report concluded.

Calling the “lack of affordability” of healthcare “a pervasive problem” in the U.S., the study cited “a fragmented insurance system” as a key factor contributing to this outcome.

According to the report:

“While the ACA’s [Affordable Care Act’s] Medicaid expansions and subsidized private coverage have helped fill the gap, 26 million Americans are still uninsured, leaving them fully exposed to the cost drivers in the system.

“Cost has also fueled growth of private plan deductibles, leaving about a quarter of the working-age population underinsured.”

As a result, “U.S. patients are more likely than their peers in most other countries to report they don’t have a regular doctor or place of care and face limited options for getting treatment after regular office hours,” the report notes.

‘Americans live the shortest lives and have the most avoidable deaths’

Despite higher-than-average healthcare spending and the high cost of health services for patients, the report found that the U.S. ranks last among the countries studied in health outcomes, noting that “Americans live the shortest lives and have the most avoidable deaths.”

According to the report, the U.S. ranks last in 4 of 5 health outcome metrics included in the study, including life expectancy and rates of preventable and treatable deaths.

“Life expectancy is more than four years below the 10-country average, and the U.S. has the highest rates of preventable and treatable deaths for all ages,” the report noted. “The ongoing substance use crisis and the prevalence of gun violence in the U.S. contribute significantly to its poor outcomes.”

Malone called this finding “the most compelling inditement” of the U.S. healthcare system and the U.S. “medical-industrial, pharmaceutical-industrial and federal public health service complex.”

The report compared poor COVID-19 performance in the U.S. with other countries, including Australia, New Zealand and Switzerland.

The report praised these countries for implementing “stringent border controls, lockdowns, quarantine requirements, and movement restrictions” during the pandemic.

The report did not mention that Sweden’s health outcome metrics were similar to those in Australia, New Zealand and Switzerland — even though Sweden eschewed lockdowns and most COVID-19-related restrictions during the pandemic.

U.S. not protecting ‘the health and welfare of its residents’

“Despite spending a lot on health care, the United States is not meeting one of the principal obligations of a nation: to protect the health and welfare of its residents,” the report concluded. “The U.S., in failing this ultimate test of a successful nation, remains an outlier.”

Citing “ample opportunities for cross-national learning,” the report included several recommendations for areas where the U.S. can improve its healthcare performance.

It suggested the U.S. “continue to reduce financial barriers to access to care by extending coverage to the remaining uninsured,” including “reducing the cost of care, which is driven primarily by high prices charged by providers.”

The report also recommended the U.S. minimize “the variation and complexity of insurance plans,” and “address the uncontrolled consolidation of health care resources in local markets, which helps drive prices higher and makes insurance less affordable for Americans.”

This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.

AMA Lyme Disease: A Clinician Toolkit (Part 2)

I must have missed Part 1.  Here it is:  https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/32867249

In short, the CDC gave the AMA 5M in taxpayer dollars to come up with an IDSA Toolkit to improve care for patients with prolonged symptoms and concerns about Lyme disease.

Hopefully you can see the inherent problems with this.  Once again, the wolf is being asked how to take care of the chickens.  Dr. Paul Auwaerter particularly appears to speak out of both sides of his mouth.

Further, the American Medical Association (AMA) is a completely corrupt, tyrannical institution.  It opposes free speech, instructs doctors to deceive, is behind persecuting doctors who think for themselves, was found GUILTY in a court of law of conspiring against chiropractic, and has completely monopolized medicine with the help of the Rockefellers.

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/32919062?

American Medical Association Lyme Disease: A Clinician Toolkit (Part 2)

Carl Tuttle
Hudson, NH, United States
Sep 25, 2024

The letter below is a follow-up to the previous petition update: https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/32867249

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “pauwaert@jhmi.edu” <pauwaert@jhmi.edu>, “pgauwaerter@gmail.com” <pgauwaerter@gmail.com>
Cc: “cbb0@cdc.gov” <cbb0@cdc.gov>, “jjohnson@genevausa.org” <jjohnson@genevausa.org>, “theerhisamariee@gmail.com” <theerhisamariee@gmail.com>, “jaucott@jhmi.edu” <jaucott@jhmi.edu>, “jraitt1@stanford.edu” <jraitt1@stanford.edu>, “dclauw@med.umich.edu” <dclauw@med.umich.edu>, “john.leong@tufts.edu” <john.leong@tufts.edu>, “avindra.nath@nih.gov” <avindra.nath@nih.gov>, “charles.chiu@ucsf.edu” <charles.chiu@ucsf.edu>, “elliot.cowan@partnersindiagnostics.com” <elliot.cowan@partnersindiagnostics.com>, “beth.jaworski@nih.hhs.gov” <beth.jaworski@nih.hhs.gov>, “roger@lundquist.org” <roger@lundquist.org>, “rachele.hendricks.sturrup@duke.edu” <rachele.hendricks.sturrup@duke.edu>, “info@lymebiobank.org” <info@lymebiobank.org>, “lorrainejohnson@outlook.com” <lorrainejohnson@outlook.com>, “wendyadams1@gmail.com” <wendyadams1@gmail.com>, “Leith.States@hhs.gov” <Leith.States@hhs.gov>, “tindall.matt@gmail.com” <tindall.matt@gmail.com>, “stacie.hudgens@clinoutsolutions.com” <stacie.hudgens@clinoutsolutions.com>, “raymond_dattwyler@nymc.edu” <raymond_dattwyler@nymc.edu>, “timothy.sellati@globallymealliance.org” <timothy.sellati@globallymealliance.org>, “nklimas@nova.edu” <nklimas@nova.edu>, “kester@genevausa.org” <kester@genevausa.org>, “nicole@nicolemalachowski.com” <nicole@nicolemalachowski.com>, “marcom@genevausa.org” <marcom@genevausa.org>, “stephen.gluckman@pennmedicine.upenn.edu” <stephen.gluckman@pennmedicine.upenn.edu>, “epocratesMedia@athenahealth.com” <epocratesMedia@athenahealth.com>, “epocrates@athenahealth.com” <epocrates@athenahealth.com>, “achen@mathematica-mpr.com” <achen@mathematica-mpr.com>, “info@mathematica-mpr.com” <info@mathematica-mpr.com>, “pdecker@mathematica-mpr.com” <pdecker@mathematica-mpr.com>, “lwx1@cdc.gov” <lwx1@cdc.gov>, “frederick.chen@ama-assn.org” <frederick.chen@ama-assn.org>, “gmarx@cdc.gov” <gmarx@cdc.gov>, “acoyne@mathematica-mpr.com” <acoyne@mathematica-mpr.com>, “jconstantine@mathematica-mpr.com” <jconstantine@mathematica-mpr.com>, “ctrenholm@mathematica-mpr.com” <ctrenholm@mathematica-mpr.com>, “tbarnes@mathematica-mpr.com” <tbarnes@mathematica-mpr.com>, “sboudreau@mathematica-mpr.com” <sboudreau@mathematica-mpr.com>, “jdevallance@mathematica-mpr.com” <jdevallance@mathematica-mpr.com>, “sara.berg@ama-assn.org” <sara.berg@ama-assn.org>, “jack.resneck@ucsf.edu” <jack.resneck@ucsf.edu>, “jack.resneck@ama-assn.org” <jack.resneck@ama-assn.org>, “todd.unger@ama-assn.org” <todd.unger@ama-assn.org>, “jon.burkhart@ama-assn.org” <jon.burkhart@ama-assn.org>, “karen.kmetik@ama-assn.org” <karen.kmetik@ama-assn.org>, “sanjay.desai@ama-assn.org” <sanjay.desai@ama-assn.org>, “aaguilar@webmd.net” <aaguilar@webmd.net>, “DFlapan@Medscape.net” <DFlapan@Medscape.net>, “lkane@medscape.net” <lkane@medscape.net>, “gamiller@medscape.net” <gamiller@medscape.net>, “dolmos@webmd.net” <dolmos@webmd.net>, “sarah.wright@webmd.net” <sarah.wright@webmd.net>, “editor2@webmd.net” <editor2@webmd.net>, “kg@kirstengillibrand.com” <kg@kirstengillibrand.com>, “yzhang207@zju.edu.cn” <yzhang207@zju.edu.cn>, “jonathan.kanter@usdoj.gov” <jonathan.kanter@usdoj.gov>, “Antitrust.ATR@usdoj.gov” <Antitrust.ATR@usdoj.gov>, “gheltzer@mwe.com” <gheltzer@mwe.com>, “albert.sambat@usdoj.gov” <albert.sambat@usdoj.gov>, “ddutko@rustyhardin.com” <ddutko@rustyhardin.com>, “kspeer@rustyhardin.com” <kspeer@rustyhardin.com>, “katrina.rouse@usdoj.gov” <katrina.rouse@usdoj.gov>, “loppenheimer@oppenheimer-law.com” <loppenheimer@oppenheimer-law.com>

Date: 09/25/2024 9:20 AM EDT
Subject: Re: Improving Care for Patients with Prolonged Symptoms and Concerns about Lyme Disease: A Clinician Toolkit

Dr Auwaerter,

While we wait for your reply to my previous inquiry dated Sept 2nd, I would like to call attention to the following publication you coauthored with Johns Hopkins colleague Dr. Ying Zhang in 2014:

Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library – PubMed
Jie Feng, Ting Wang, Wanliang Shi, Shuo Zhang, David Sullivan, Paul G Auwaerter & Ying Zhang

https://pubmed.ncbi.nlm.nih.gov/26038747/

Excerpt:

Findings that suggest the continued presence of B. burgdorferi in some form indicate that current Lyme disease treatment may not sufficiently eliminate B. burgdorferi persisters or that the immune system fails to clear persisting organisms or bacterial debris, which may be the underlying cause for those who suffer from unresolved Lyme disease symptoms.
Recent quote from Dr. Ying Zhang: (Now with Zhejiang University School of Medicine, Hangzhou, Zhejiang, China)

“We’re dealing with a very unique situation here. The current Lyme antibiotic does not completely eradicate Borrelia bacteria. We found this dandelion phenomenon. The mower is equivalent to the antibiotics, that chopped off the top part. But because the root, the possessor, is still there, they can grow back. You need drugs targeting both parts in order to more effectively cure this persistent form of the disease.”

Dr Auwaerter,

These findings appear to be missing from your recorded interview on the AMA website: “Toolkit to Improve Care for Patients with Prolonged Symptoms and Concerns about Lyme Disease”

For the record there are seven published studies finding Dapsone effective in treating chronic Lyme disease as reported by Dr. Richard Horowitz and colleagues: 1, 2, 3, 4, 5, 6, 7

In contrast Dr. Auwaerter, you were the lead author who published the hit piece in the Lancet Infectious Diseases condemning these physicians:

Antiscience and ethical concerns associated with advocacy of Lyme disease (2011)
https://pubmed.ncbi.nlm.nih.gov/21867956/

The 5-million-dollar grant given to the AMA by the CDC for this so-called “Clinician Toolkit” would have been better spent on validating antimicrobials that cure chronic Lyme. But then again if we had the correct treatment who would opt for Pfizer’s Lyme vaccine currently in phase III clinical trials ready to roll out in 2026?

Questions:

Which CDC employee/academic stands to benefit financially (patent royalties etc.) from the soon to be released OspA Pfizer Lyme vaccine and what role have these individuals played (if any) in the ongoing collusion to deny chronic Lyme disease? 

Carl Tuttle
Independent Researcher
Hudson, NH

Cc: Assistant Attorney General Jonathan Kanter, Attorney Katrina Rouse
Attorneys for the United States Antitrust Division

Assistant Attorney General Jonathan Kanter Announces Task Force on Health Care Monopolies and Collusion
https://www.justice.gov/opa/pr/assistant-attorney-general-jonathan-kanter-announces-task-force-health-care-monopolies-and

References:

1. Comparison of the Efficacy of Longer versus Shorter Pulsed High Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome with Bartonellosis and Associated Coinfections.
https://pubmed.ncbi.nlm.nih.gov/37764145/

2. Effect of dapsone alone and in combination with intracellular antibiotics against the biofilm form of B. burgdorferi.
https://pubmed.ncbi.nlm.nih.gov/32993780/

3. Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review.
https://pubmed.ncbi.nlm.nih.gov/35884166/

4. Combining Double-Dose and High-Dose Pulsed Dapsone Combination Therapy for Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome and Co-Infections, Including Bartonella: A Report of 3 Cases and a Literature Review.
https://pubmed.ncbi.nlm.nih.gov/38792737/

5. Efficacy of Double-Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-infections: A Report of Three Cases and Retrospective Chart Review.
https://pubmed.ncbi.nlm.nih.gov/33105645/

6. Precision medicine: retrospective chart review and data analysis of 200 patients on dapsone combination therapy for chronic Lyme disease/post-treatment Lyme disease syndrome: part 1.
https://pubmed.ncbi.nlm.nih.gov/30863136/

7. Precision Medicine: The Role of the MSIDS Model in Defining, Diagnosing, and Treating Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome and Other Chronic Illness: Part 2.
https://pubmed.ncbi.nlm.nih.gov/30400667/
Previous inquiry to Auwaerter dated Sept 2nd:
https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/32867249

When Lyme Patients Must Fight to be Believed by Doctors

https://www.lymedisease.org/lyme-patients-fight-to-be-believed/

When Lyme patients must fight to be believed by doctors

By Nancy Dougherty

Illness invalidation by medical professionals—sometimes called “gaslighting”—is an underappreciated and understudied problem in Lyme disease.

Many Lyme disease patients complain not only of fighting to recover their health but also of fighting to be believed by health care practitioners.

Expecting to receive understanding and proficient care from medical professionals, many instead experience having their persistent debilitating symptoms dismissed, minimized, disbelieved and/or psychologized.

How common is the occurrence of medical gaslighting in Lyme disease? Is illness invalidation by medical professionals related to disease severity? Are there specific constituencies who are being affected more than others?

These are some of the questions that a team of researchers led by Alison Rebman, MPH, Assistant Professor in Medicine and Director for Clinical and Epidemiological Research at the Johns Hopkins Lyme Disease Research Center at Johns Hopkins Medicine, set out to identify and quantify in a cohort of well-characterized Lyme disease patients.

Invalidating encounters

The Johns Hopkins study, published in August 2024 in Scientific Reports, finds that invalidating encounters with medical professionals are common for post-treatment Lyme disease (PTLD) patients, particularly women and younger patients, and also are linked to higher illness severity.

Lyme disease is the most common tick and vector-borne disease in the US with about 500,000 new cases per year. Lyme infections are expanding geographically, and acute and chronic cases are on the rise in the US and Eurasia. Lyme infection-associated chronic illness affects around 2 million Americans and can be difficult to properly diagnose and effectively treat.

A Lyme infection can affect multiple body systems including musculoskeletal, neurologic, and cardiovascular. Patients with early diagnosis and appropriate treatment usually get better. However, about 10-20% of patients even when treated promptly with standard of care antibiotics do not return to health and are functionally impaired by persistent musculoskeletal pain, crushing fatigue, and cognitive dysfunction, known in the research setting as post-treatment Lyme disease (PTLD).

Patients frequently refer to this as “chronic Lyme.” Misdiagnosis and delayed treatments further increase the risk for PTLD as well as for more broadly defined community-based Lyme infection-associated chronic illness or “chronic Lyme.”

Women and younger patients

In the Johns Hopkins study, 49% of the PTLD patients reported a lack of understanding and 29% experienced discounting from medical professionals. Additionally, women and younger patients were at higher risk for experiencing more invalidation than men or older age patients.

The study found, “Before their initial diagnosis of Lyme disease, approximately half (51.3%) had first been told that their symptoms represented another illness or condition. This high rate is consistent with the hypothesis that diagnosis and treatment delays, and possibly exposure to inappropriate treatment, may be risk factors for PTLD.”

Women more often received alternative diagnoses (such as another contested illness like fibromyalgia or ME/CFS and/or a psychological illness) which in turn correlated with more discounting and lack of understanding. PTLD patients who reported the highest levels of illness invalidation were discovered to have greater symptom severity, lower quality of life, and less trust in physicians.

The pervasiveness of Lyme disease illness invalidation and the consequential negative effects on illness burden and health outcomes are not broadly known by medical professionals.

Improved physician education is needed to help engender more patient-centered paradigms that incorporate the patient illness experience and better recognize how that experience may impact the healing process.

National Academies look at IACI

The National Academies of Sciences, Engineering and Medicine (NASEM) has helped validate infection- associated chronic illnesses as being significant public health problems that need greater national attention, a coordinated strategy, and considerably more federal resources.

NASEM held its first national workshop on infection-associated chronic illnesses (IACI) in June 2023 to explore overlapping symptoms and biologic pathways for IACIs including Lyme disease, long COVID, ME/CFS, MS, and others.

In July 2024, a follow-up NASEM meeting focused specifically on Lyme infection-associated chronic Illness. Both forums discussed the importance of listening to and incorporating patients’ illness experience perspectives into improving diagnostic and treatment approaches. For example, patient-driven data such as MyLymeData can be leveraged to improve research and clinical care. It is vital to listen to patients especially when diagnostics are problematic, treatments are inadequate, and the science is contested or evolving.

Building upon insights and collaborative momentum from the NASEM IACI meetings, a coalition of advocates (patient, scientific and medical) are now calling for the creation of a new National Institutes of Health (NIH) office to help strengthen and coordinate research across infection-associated chronic conditions and illnesses including Lyme infection-associated chronic illness, Long COVID, ME/CFS, PANS/PANDAS, POTS/dysautonomia and others.

Listening to patients will be key to advancing solutions, reducing invalidating patient-practitioner encounters, and improving health outcomes.

Nancy Dougherty is an education and communications consultant for the Johns Hopkins Lyme Disease Research Center. Other research investigations at the Center include Pilot Treatment Trials and the SLICE Studies.

_____________

For more:

Researchers Say New Lyme Test Can Detect Lyme Within 14 Days of Infection

https://www.lymedisease.org/detecting-lyme-within-14-days/

Researchers say this test can detect Lyme within 14 days of infection

Focus on Lyme and Aces Diagnostics Inc. has announced a breakthrough in Lyme disease diagnosis with a new test that detects the disease at all stages, including the crucial first 14 days post-infection, with over 90% accuracy.

Aces Diagnostics is developing and manufacturing this test, aiming for FDA clearance to make it accessible to all patients.

LymeSeek™, developed through a collaboration between Tulane University and Focus on Lyme, combines advanced biomarker research from Tulane’s Monica Embers and nine years of intensive work funded by Focus on Lyme. Enhanced by machine learning, this innovative diagnostic promises to reshape Lyme disease detection.

“Previous tests have been less than 50% accurate, especially in the early stages,” said Tammy Crawford, CEO of Aces Diagnostics. “This has led to countless patients being misdiagnosed or undiagnosed, resulting in prolonged suffering. LymeSeek will change that, providing a reliable diagnostic tool that can save lives.”

Aces Diagnostics Team

The CDC reports that nearly 500,000 people in the U.S. are diagnosed with Lyme disease each year. Globally, 14.5% of the population is affected, with many suffering from chronic symptoms due to delayed diagnosis. A Johns Hopkins study revealed that 38% of Lyme patients continue to experience symptoms six months post-diagnosis, underscoring the need for improved testing.

Simplifying diagnosis

“Current Lyme testing involves multiple steps, with results taking over a week and requiring subjective interpretation,” said Aces Diagnostics Co-Founder Holly Ahern.

“LymeSeek™ will replace this cumbersome process, enabling earlier diagnosis and reducing chronic illness caused by delayed or missed diagnoses.”

Crawford and Ahern are personally invested in this mission, both having daughters who battled Lyme disease. “An early diagnosis could have spared them years of suffering,” said Crawford.

Aces Diagnostics Inc. brings together a team with over 50 years of combined experience in Lyme disease research, backed by a distinguished advisory board that includes experts from Johns Hopkins UniversityColumbia University, and Tulane University. The company is already advancing development and manufacturing efforts and pursuing early FDA clearance to make LymeSeek™ available to the public by the third quarter of 2026.

SOURCE: Focus on Lyme

______________

**Comment**

Testing has been and continues to be a major problem with Lyme/MSIDS for numerous reasons, one of the biggest being the fact many are coinfected with numerous pathogens that mainstream medicine and research never discuss.  These coinfected patients are some of the sickest but are kicked to the curb because testing doesn’t reveal what’s inside them.

While this new test is a step in the right direction, it still doesn’t address those who have been infected for decades or those who are coinfected.  It’s like comparing apples to oranges and until these issues are addressed, it remains a foreign language to mainstream medicine.

The Johns Hopkins study showing nearly 40% go on to suffer symptoms 6 months post-diagnosis is still low in my opinion due to the fact so many are never diagnosed in the first place and so many are infected with multiple things that are never picked up on testing.

But, one must remain hopeful……

For more:

FREE Online Premiere of VAXXED III

https://vaxxed3.childrenshealthdefense.org/  REGISTER HERE

Miss the theater premiere for VAXXED III?

Do not fear – there is now a FREE online premiere

Date:  Friday, October 4, 2024

Time: 7 p.m. ET, 4 p.m. PT, 6 p.m. CT (Wisconsin)

Please join Children’s Health Defense Films for a FREE online premiere. In order to view the film, please sign up with your email address in advance.

We encourage you to share this event far and wide. As you know, CHD is 100% donor-funded. We still need to raise money for this film, but we have decided it’s critical to share this important documentary with the world and make sure this message reaches as many people as possible. If you would like to help support the film, you still can at the link below.

If you saw the film this week, you know that watching Vaxxed III on the big screen with a crowd was POWERFUL, so we encourage you to plan watch parties with your friends and loved ones, as well as invite new people who might benefit from watching this film.

Once you sign up, you will receive a follow-up email with a direct link to watch the virtual event on Oct 4.

In solidarity for transparency and health freedom,

The Children’s Health Defense Team

https://www.naturalnews.com/2024-09-13-vaxxed-3-exposes-injuries-deaths-vaccines-hospital-protocols

Upcoming VAXXED 3 documentary exposes widespread injuries and deaths caused by vaccines and hospital protocols

09/13/2024  Lance D Johnson

Article Excerpts:

This jarring documentary exposes widespread injuries and deaths caused by vaccines and hospital protocols that were mandated during the covid-19 scandal.

The documentary includes serious testimony from over a thousand interviews with everyday people, including medical professionals, whistleblowers and family members whose lives were shattered by the hospital protocols and mandatory vaccines.

The documentary is a culmination of testimonies gathered over a period of nine months, during which the Children’s Health Defense team traveled across the United States in a bus, documenting stories of vaccine injury, medical error and wrongful death.

“These were fundamental violations of human rights,” said Kim Mack Rosenberg, CHD general counsel. These human rights abuses led to medical atrocities at scale.  (See link for article)

The reality of widespread iatrogenic error and vaccine holocaust cannot be censored
  • Research is piling up to reveal that the mRNA vaccines increasingly weaken the immune system with each booster.  Multiple vaccinations causing a class switch in antibody production to an overproduction of IgG4, the antibody responsible for dampening immune response, and underproduction of IgG1 and IgG3, the antibodies responsible for cancer surveillance.
  • Now a ‘vaccine’ manufacturer is suing researchers for defamation and are demanding a retraction of a study describing adverse events after COVID injections.  Over 250 scientists, researchers, ethicists, doctors and patients have signed an open letter addressed to BBIL, ICMR and the editor at Drug Safety, demanding the lawsuit be withdrawn, and the study remain published.
  • Speaking of cancer, Amazon has excommunicated Dr. Paul Marik, another COVID dissident who led the charge for ivermectin and wrote Cancer Care: The Role of Repurposed Drugs and Metabolic Interventions in Treating Cancer.  Amazon has accused him of publishing titles with misleading content that have the potential to mislead or defraud our customers.
  • A chill wind passed through the dissident medical profession this week when Dr Sam White was permanently erased from the medical register for simply resigning his post and refusing to promote the clot shots.  It’s a clear message to other doctors considering speaking out.
  • And a chilling court case in Austria sounds like it could have come right out of a dystopian novel. An insane, vindictive prosecutor and a compliant judge convicted a 54-year-old Austrian woman with “grossly negligent homicide” for “fatally infecting her neighbor with COVID-19.” The Austrian prosecutors argued that the woman came in contact with her neighbor in a stairwell and shared viral DNA, before the neighbor got sick with COVID-19 and died of pneumonia.  This outrageous case sets a dangerous legal precedent, enshrining the germ theory as definitive legal doctrine, and making everyday activities subject to police state surveillance and prosecution. With this insane case, anyone with a damaged immune system can prosecute anyone they want, without serious evidence, for their own sicknesses and chronic diseases. Source:  https://lionessofjudah.substack.com/p/insane-covid-court-convicts-austrian